AffiliationDepartment of Experimental Radiation Oncology, Paterson Institute for Cancer Research, Manchester, UK.
MetadataShow full item record
AbstractA series of compounds based on an asymmetrical protoporphyrin molecule have been examined. The paired groups of sensitizers differed in terms of the presence or absence of a permanent positive charge, in the alkyl side chain length and in having either a primary or secondary amine substituent. The effects of these variables on drug uptake, partition coefficient and photodynamic cell kill were tested. Drug uptake and partition coefficient were shown to be correlated. Differences in gross uptake were found within paired groups of sensitizers although cell-associated uptake alone did not correlate with clonogenic cell survival. Of the compounds tested it was the sensitizers with alkyl side chains, rather than the permanently positively charged compounds, which resulted in the greatest degree of clonogenic cell kill.
CitationNovel asymmetric photosensitizers: an in vitro study. 1996, 105 (2):187-93 Cancer Lett.
- Pharmacokinetic and therapeutic outcome in melanoma cells, of the administration of symmetric and asymmetric cationic photosensitizers.
- Authors: Haylett AK, Ross S, Truscott TG, Moore JV
- Issue date: 1995 Jan 27
- Killing malignant melanoma cells with protoporphyrin IX-loaded polymersome-mediated photodynamic therapy and cold atmospheric plasma.
- Authors: Wang M, Geilich BM, Keidar M, Webster TJ
- Issue date: 2017
- Photodynamic antitumor agents: beta-methoxyethyl groups give access to functionalized porphycenes and enhance cellular uptake and activity.
- Authors: Richert C, Wessels JM, Müller M, Kisters M, Benninghaus T, Goetz AE
- Issue date: 1994 Aug 19
- Photodynamic therapy.
- Authors: Phillips D
- Issue date: 1993-1994
- Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
- Authors: Megerian CA, Zaidi SI, Sprecher RC, Setrakian S, Stepnick DW, Oleinick NL, Mukhtar H
- Issue date: 1993 Sep